The Medical Imaging & Technology Alliance (MITA) has released a new white paper outlining the differences between servicing and remanufacturing activities for medical imaging devices, urging the FDA to clarify its own definitions of the two terms. 

The FDA has published a new letter to providers in radiology, pathology, emergency medicine and several other specialties with updated information related to breast implant associated-anaplastic large cell lymphoma (BIA-ALCL).

New Mexico Gov. Michelle Lujan Grisham has signed the state’s breast density reporting legislation into law.

Emergency room (ER) doctors at Rhode Island Hospital in Providence have been delivered subpoenas charging them with medical misconduct for incorrectly ordering imaging examinations, according to an article published Jan. 30 by Politico.

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and American College of Nuclear Medicine (ACNM) submitted a joint statement to the Nuclear Regulatory Commission (NRC) opposing potential changes in the NRC’s training and experience requirements for authorized users to administer radiopharmaceuticals.  

How will the Protecting Access to Medicare Act (PAMA) of 2014 impact emergency department (ED) care in 2020 and beyond? That’s precisely what the authors of a new study published in Radiology wanted to find out.

The 2.3 percent medical device tax, originally implemented as a piece of the Affordable Care Act, is currently suspended until 2020. Could 2019 be the year it gets repealed for good?

The FDA announced that it approved 106 novel medical devices in 2018, surpassing the previous record of 98 set just one year prior. Nine devices also received the agency’s Breakthrough Device Designation.

Implementation of the Affordable Care Act (ACA) did not make a significant impact on breast cancer care at a safety net hospital in California, according to findings published in the American Journal of Surgery. The authors noted, however, that more patients did have health insurance in the two years following implementation.

Though it has been in place for decades, the practice of patient shielding in radiology should be abandoned, according to a new analysis published in the American Journal of Roentgenology.

The FDA has published the final guidance for its new regulatory pathway aimed at helping medical device manufacturers gain 510(k) approval by meeting certain safety and performance criteria. 

The U.S. Preventive Services Task Force (USPSTF) has published a draft recommendation statement and draft evidence review that says clinicians should offer “risk-reducing medications” to women at an increased risk for breast cancer.